Novanta Inc.

Fundamentals5.0
Price Action4.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Strong Liquidity
  • Margin Pressure
  • Equity Dilution

AI
AI Summary

5.0

NOVT's investment case has shifted to proving that Riverpoint-driven growth and synergies can restore margins and generate per-share returns above the dilution cost; with ~94x earnings valuation, investors should wait for tangible margin recovery and acquisition accretion before underwriting upside.

MedicalGrowth
DilutionRisk
Integration‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • •Strong Liquidity
  • •Margin Pressure
  • •Equity Dilution

NOVT offers strong liquidity and cash flow but faces margin pressure, shareholder dilution, modest returns, and a demanding valuation—favor caution.

Liquidity
Valuation

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Persistent selling pressure
  • •Critical support test
  • •Recovery hurdles ahead

NOVT remains bearish below its last-month average, with $132.80–$133.00 support critical; a break lower signals further downside, while reclaiming $140.05 and $142.57 would improve momentum.

Bearish
TechnicalSetup
Support Level: $132.80–$133.00
Resistance Level: $138.23–$140.05, then $142.57

Sharp decline from $149.31 to $132.80 in eight days

Sentiment & News

6.0

Key News Insights:

  • •New institutional stake
  • •Upcoming investor conference
  • •Robotics sector tailwind

Novanta gained institutional backing and investor visibility amid favorable robotics and AI sector interest.

InstitutionalInterest
RoboticsExposure

The developments modestly support Novanta's visibility and sentiment among technology-focused investors